Grifols (GRFS) Other Accumulated Expenses (2010 - 2021)

Grifols (GRFS) reported Other Accumulated Expenses of $250.8 million for Q4 2021, up 37.36% on a YoY basis from $182.6 million in Q4 2020, and up 37.36% quarter-over-quarter from $182.6 million in Q4 2020.

Grifols (GRFS) Other Accumulated Expenses (2010 - 2021) Analysis & Trends

Grifols has reported Other Accumulated Expenses for 12 years, with the latest figure at $250.8 million in Q4 2021.

  • For the quarter ending Q4 2021, Other Accumulated Expenses rose 37.36% year-over-year to $250.8 million; the trailing twelve-month figure through Dec 2021 stood at $250.8 million (up 37.36% YoY), and the FY2021 full-year result was $250.8 million, up 37.36% from the prior year.
  • Other Accumulated Expenses for Q4 2021 stood at $250.8 million, up from $182.6 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $1.1 billion in Q4 2018, with the low at $141.5 million in Q2 2017.
  • Historically, Other Accumulated Expenses has averaged $773.3 million across 5 years, with a median of $1.0 billion in 2018.
  • Annual changes were most pronounced in 2017 — Other Accumulated Expenses surged 540.14% — and 2020, when it plunged 83.59%.
  • Grifols' Other Accumulated Expenses stood at $968.9 million in 2017, then increased by 15.44% to $1.1 billion in 2018, then retreated by 0.52% to $1.1 billion in 2019, then tumbled by 83.59% to $182.6 million in 2020, then jumped by 37.36% to $250.8 million in 2021.
  • The last three Other Accumulated Expenses figures came in at $250.8 million (Q4 2021), $182.6 million (Q4 2020), and $1.1 billion (Q3 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Grifols 6.05 Bn 5.09 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2021 250.84 Mn
Dec 31, 2020 182.61 Mn
Sep 30, 2020 1.08 Bn
Mar 31, 2020 1.11 Bn
Dec 31, 2019 1.11 Bn
Sep 30, 2019 1.09 Bn
Dec 31, 2018 1.12 Bn
Sep 30, 2018 975.69 Mn
Jun 30, 2018 165.40 Mn
Mar 31, 2018 1.09 Bn
Dec 31, 2017 968.93 Mn
Jun 30, 2017 141.55 Mn
Dec 31, 2016 151.36 Mn
Sep 30, 2016 133.26 Mn
Jun 30, 2016 125.37 Mn
Dec 31, 2015 147.61 Mn
Sep 30, 2015 150.33 Mn
Jun 30, 2015 139,030.09
Mar 31, 2015 138.08 Mn
Dec 31, 2014 184.83 Mn